scispace - formally typeset
Search or ask a question
Institution

Roussel Uclaf

About: Roussel Uclaf is a based out in . It is known for research contribution in the topics: Alkyl & Alkoxy group. The organization has 1888 authors who have published 2338 publications receiving 36508 citations.
Topics: Alkyl, Alkoxy group, Aryl, Carbon, Carboxylic acid


Papers
More filters
Patent
10 Dec 1987
TL;DR: In this article, a compound is selected from the group consisting of azaspirodecane derivatives of the formula STR1, where R is a compound chosen from the groups consisting of hydrogen, fluorine, chlorine, bromine, alkoxy of 1 to 3 carbon atoms, --NO2, --NH2 and CH3 S-- in the 4,5 or 6 position of the ring.
Abstract: A compound selected from the group consisting of azaspirodecane derivatives of the formula ##STR1## wherein R is selected from the group consisting of hydrogen, fluorine, chlorine, bromine, alkoxy of 1 to 3 carbon atoms, --NO2, --NH2 and CH3 S-- in the 4,5 or 6 position of the ring, R' is oxo or hydrogen or --OH or alkyl of 1 to 3 carbon atoms and the dotted line indicates a carbon-carbon bond in the 2,3-position, n is 2,3,4 or 5 and the dotted line in the piperidyl ring is an optional carbon-carbon bond and their non-toxic, pharmaceutically acceptable acid addition salts having remarkable anxiolytic activity.

5 citations

Patent
28 Apr 1993
TL;DR: In this paper, a compound is selected from the group consisting of a compound of the formula ##STR1## wherein R 1 is hydrogen or alkyl of 1 to 3 carbon atoms, R 2 is alkyyl of 1-to-3 carbon atoms or cycloalkyl of 3 to 6 carbon atoms.
Abstract: A compound selected from the group consisting of a compound of the formula ##STR1## wherein R 1 is hydrogen or alkyl of 1 to 3 carbon atoms, R 2 is alkyl of 1 to 3 carbon atoms or cycloalkyl of 3 to 6 carbon atoms, R 3 is --COOR 6 , R 6 is hydrogen or alkyl of 1 to 3 carbon atoms, R 4 is selected from the group consisting of halogen, --CN, --NO 2 , --SCH 3 , alkylcarbonyl of 1 to 6 alkyl carbon atoms, --CX 3 , --WCX 3 , --(CH 2 ) n --CX 3 , --(CX 2 ) n --CX 3 , --W--(CX 2 ) n --CX 3 , and --W--(CH 2 ) n --CX 3 , X is halogen, W is --O-- or --S--, n is 1, 2 or 3, R 5 is selected from the group consisting of hydrogen, alkyl of 1 to 3 carbon atoms and cycloalkyl of 3 to 6 carbon atoms and their salts with non-toxic pharmaceutically acceptable bases with the proviso that if R 2 is alkyl of 1 to 3 carbon atoms, R 1 is hydrogen and R 4 is selected from the group consisting of halogen, --CX 3 , --(CH 2 ) n --CX 3 , --(CX 2 ) n --CX 3 , --OCX 3 , --O--(CX 2 ) n --CX 3 , and --O--(CH 2 ) n --CX 3 , X is halogen and n is 1, 2 or 3, R 5 cannot be hydrogen having anti-inflammatory activity and their preparation and intermediates.

5 citations

Patent
26 Jul 1976
TL;DR: In this article, the authors presented a 7-amino-benzocycloheptenes of the formula STR1, where X is selected from the group consisting of hydrogen, chlorine, bromine and iodine in the 2- or 4-position when a halogen, Y and Z are hydrogen or together form a double bond, and R 1 and R 2 taken together with the nitrogen atom to which they are attached form a saturated heterocycle of 4 to 6 carbon atoms and optionally containing another hetero-atom and optionally substituted with an alkyl
Abstract: Novel 7-amino-benzocycloheptenes of the formula ##STR1## wherein X is selected from the group consisting of hydrogen, chlorine, bromine and iodine in the 2- or 4-position when a halogen, Y and Z are hydrogen or together form a double bond, R is selected from the group consisting of hydrogen, alkyl of 1 to 5 carbon atoms and phenyl optionally substituted with fluorine, chlorine, methyl or methoxy, R 1 is selected from the group consisting of hydrogen, alkyl of 1 to 5 carbon atoms and alkenyl of 2 to 5 carbon atoms and R 2 is selected from the group consisting of alkyl of 1 to 5 carbon atoms and alkenyl of 2 to 5 carbon atoms and R 1 and R 2 taken together with the nitrogen atom to which they are attached form a saturated heterocycle of 4 to 6 carbon atoms and optionally containing another hetero-atom and optionally substituted with an alkyl of 1 to 5 carbon atoms and their non-toxic, pharmaceutically acceptable acid addition salts having antidepressive activity and their preparation and novel intermediates.

5 citations

Journal ArticleDOI
TL;DR: The Documentation Ring of the chemical and pharmaceutical industries uses a punched card system to record chemical reactions as mentioned in this paper, where starting materials and the end products are encoded with a fragmentation code, and the bonds that change during the reaction are recorded in the same way.
Abstract: The Documentation Ring of the chemical and pharmaceutical industries uses a punched card system to record chemical reactions. The starting materials and the end products are encoded with a fragmentation code, and the bonds that change during the reaction are recorded in the same way. Reaction modifiers and physical data can also be stored. In the case of multistage reactions, both the individual stages and various groups of stages are recorded.

5 citations


Authors

Showing all 1888 results

NameH-indexPapersCitations
Fernand Labrie11088548308
Lionel H. Opie8451925964
Alain Bélanger7024416469
Michel J. Tremblay5327310485
Pierre Monsan512168049
Samir Z. Zard5057510739
Alejandro Aruffo4712314084
Samuel S.C. Yen47966865
Dominique Maraninchi471888108
Serge Erlinger461528200
Romain Lefebvre402215269
William B. Motherwell393056357
Jean-Pierre Raynaud381045075
André Lemay381144264
Patrick J. Creaven321023435
Network Information
Related Institutions (5)
Merck & Co.
48K papers, 1.9M citations

85% related

Novartis
50.5K papers, 1.9M citations

85% related

Pfizer
37.4K papers, 1.6M citations

84% related

Eli Lilly and Company
22.8K papers, 946.7K citations

84% related

AstraZeneca
23.4K papers, 938.2K citations

82% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
20181
20114
20104
20091
20084
20072